GB2115811B - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
GB2115811B
GB2115811B GB08304011A GB8304011A GB2115811B GB 2115811 B GB2115811 B GB 2115811B GB 08304011 A GB08304011 A GB 08304011A GB 8304011 A GB8304011 A GB 8304011A GB 2115811 B GB2115811 B GB 2115811B
Authority
GB
United Kingdom
Prior art keywords
ergot alkaloids
ergot
alkaloids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08304011A
Other versions
GB2115811A (en
GB8304011D0 (en
Inventor
Georg Bolliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8304011D0 publication Critical patent/GB8304011D0/en
Publication of GB2115811A publication Critical patent/GB2115811A/en
Application granted granted Critical
Publication of GB2115811B publication Critical patent/GB2115811B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB08304011A 1982-02-17 1983-02-14 Ergot alkaloids Expired GB2115811B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98782 1982-02-17

Publications (3)

Publication Number Publication Date
GB8304011D0 GB8304011D0 (en) 1983-03-16
GB2115811A GB2115811A (en) 1983-09-14
GB2115811B true GB2115811B (en) 1985-08-14

Family

ID=4199836

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08304011A Expired GB2115811B (en) 1982-02-17 1983-02-14 Ergot alkaloids

Country Status (19)

Country Link
JP (1) JPS58152884A (en)
AU (1) AU1142083A (en)
BE (1) BE895898A (en)
CS (1) CS236786B2 (en)
DD (1) DD209458A5 (en)
DE (1) DE3304361A1 (en)
DK (1) DK66483A (en)
ES (1) ES8407060A1 (en)
FI (1) FI830462L (en)
FR (1) FR2521562B1 (en)
GB (1) GB2115811B (en)
GR (1) GR79562B (en)
IT (1) IT1197578B (en)
NL (1) NL8300558A (en)
NO (1) NO830482L (en)
PL (1) PL240608A1 (en)
PT (1) PT76242B (en)
SE (1) SE8300865L (en)
ZA (1) ZA831089B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid
GB0808326D0 (en) * 2008-05-08 2008-06-18 E Therapeutics Plc Compositions and methods for the treatment of fybromyalgia

Also Published As

Publication number Publication date
PT76242A (en) 1983-03-01
FR2521562B1 (en) 1985-10-25
DK66483A (en) 1983-08-18
DK66483D0 (en) 1983-02-15
DE3304361A1 (en) 1983-08-25
PT76242B (en) 1986-01-10
FR2521562A1 (en) 1983-08-19
PL240608A1 (en) 1984-10-08
ES519811A0 (en) 1984-08-16
ZA831089B (en) 1984-09-26
NO830482L (en) 1983-08-18
BE895898A (en) 1983-08-16
NL8300558A (en) 1983-09-16
GB2115811A (en) 1983-09-14
GB8304011D0 (en) 1983-03-16
SE8300865D0 (en) 1983-02-16
SE8300865L (en) 1983-08-18
FI830462L (en) 1983-08-18
GR79562B (en) 1984-10-30
ES8407060A1 (en) 1984-08-16
IT1197578B (en) 1988-12-06
DD209458A5 (en) 1984-05-09
AU1142083A (en) 1983-08-25
CS236786B2 (en) 1985-05-15
FI830462A0 (en) 1983-02-10
IT8347734A0 (en) 1983-02-17
JPS58152884A (en) 1983-09-10

Similar Documents

Publication Publication Date Title
GB8311973D0 (en) Quinoline derivatives
DE3377796D1 (en) Quinoline derivatives
ZA833008B (en) Ergoline derivatives
GB2125041B (en) Ergot alkaloids
AU553514B2 (en) Vinca alkaloids
PH21234A (en) Ergot alkaloids
PT72785A (en) Ergoline derivatives
GB2115811B (en) Ergot alkaloids
GB2074566B (en) Ergoline derivatives
GB2092570B (en) Ergot alkaloids
ZA812103B (en) Ergoline derivatives
NZ189422A (en) Ergot peptide alkaloids
ZA83955B (en) Ergot alkaloids
GB2094798B (en) Ergot alkaloids
JPS57159783A (en) Manufacture of ergot alkaloids
GB2131674B (en) Ashtray
IE802091L (en) Ergot peptide alkaloids
GB2135307B (en) Ergot derivatives
KR840000329Y1 (en) Ashtray
KR860000957Y1 (en) Ashtray
ZA841150B (en) Ergot derivatives
GB8312447D0 (en) Ergot derivatives
IE822659L (en) Morphinane derivatives
IE820346L (en) Quinoline derivatives
AU88302S (en) Ashtray

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee